Cellectis Allogeneic Car-T Cells

Cellectis Allogeneic CAR-T Cells

Cellectis' gene edited CAR T-cells: how does it work?

Allogeneic CAR-T cells: for hematological malignancies and solid tumors ?

In the Stem Cell Jungle

UCARTCS1: a novel allogeneic CAR-T therapy for myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

What is an Allogeneic CAR T Cell?

HealthTree University Myeloma

Lecture: Creating A Universal Donor-Derived Cell Therapy, Thierry Wurch

Cellectis 2020 shareholders video

Cellectis Innovation Days- Episode 1

Cellectis Innovation Days - Episode 2

The current landscape of allogeneic CAR T-cell therapies

PBCAR0191, an allogeneic CAR T-cell therapy, in B-ALL

VJHemOnc – Video Journal of Hematology & HemOnc

An insight into CTX130: a novel allogeneic CAR-T cell therapy

VJHemOnc – Video Journal of Hematology & HemOnc

Cellectis Innovation Days- Episode 5

From Gene Editing to CAR-T cells, an insider view on the journey of Cellectis

In the Stem Cell Jungle

Allogeneic CAR T-Cell Approaches for NHL

T-cells: army of cancer killing clones | André Choulika | TEDxSaclay

Cellectis Innovation Days- Episode 3

Adaptimmune's allogeneic or 'off-the-shelf' cell therapies.

Adaptimmune Therapeutics

Advances in allogeneic CAR-T therapy in lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc